InvestorsObserver
×
News Home

Should You Add Mersana Therapeutics Inc (MRSN) Stock to Your Portfolio Wednesday?

Wednesday, October 25, 2023 03:36 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Mersana Therapeutics Inc (MRSN) Stock to Your Portfolio Wednesday?

The 9 rating InvestorsObserver gives to Mersana Therapeutics Inc (MRSN) stock puts it near the middle of the Healthcare sector. In addition to scoring higher than 43 percent of stocks in the Healthcare sector, MRSN’s 9 overall rating means the stock scores better than 9 of all stocks.

Overall Score - 9
MRSN has an Overall Score of 9. Find out what this means to you and get the rest of the rankings on MRSN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 9 would rank higher than 9 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Mersana Therapeutics Inc Stock Today?

Mersana Therapeutics Inc (MRSN) stock is trading at $1.12 as of 3:29 PM on Wednesday, Oct 25, a drop of -$0.21, or -15.47% from the previous closing price of $1.33. The stock has traded between $1.10 and $1.34 so far today. Volume today is 1,717,973 compared to average volume of 2,254,544. Click Here to get the full Stock Report for Mersana Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App